Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: JAMA Intern Med. 2014 Jul;174(7):1038–1045. doi: 10.1001/jamainternmed.2014.1927

Table 1.

Characteristics of study samples by survey cycles and statin use, 1999-2010.a

1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 P for trendb Total P for between-group comparisonc
Statin-Users

Unweighted sample, N 374 537 652 717 1,105 1,158

Weighted proportion of statin-users, % 7.5 9.2 11.1 13.5 15.4 16.5 <.001

Age Ranged, y, %
 20–39 0.7 3.8 1.9 2.6 3.8 2.5 .31 2.7 <.001
 40–59 39.8 39.5 39.6 34.8 31.9 36.8 .04 36.4 <.001
 60– 59.6 56.7 58.5 62.7 64.3 60.7 .10 60.9 <.001
Female sex, % 47.8 45.5 47.5 49.0 48.5 45.8 .89 47.4 <.001
Racial and ethnicityd, %
 Non-Hispanic white 83.8 86.1 83.3 80.1 79.9 78.2 .03 81.1 <.001
 Non-Hispanic black 4.9 6.1 7.4 10.0 8.7 9.2 .02 8.2 <.001
 Mexican American 2.0 2.1 3.1 2.8 4.2 4.8 .12 3.5 <.001
 Otherse 9.3 5.7 6.2 7.1 7.3 7.8 .81 7.2 <.001
Educational attainment, %
 > High school 41.6 53.0 45.3 50.2 48.9 55.2 .03 49.9 <.001
 High school or GEDf 31.5 27.1 33.6 30.7 29.9 24.2 .07 29.1 .002
 < High school 26.9 19.9 21.1 19.1 21.2 20.6 .28 21.0 .04
Diabetes diagnosis, % 21.5 23.9 27.7 29.7 29.8 29.3 .009 27.9 <.001
Total cholesterol level, mean (SD), mg/dL 201.9 (32.1) 195.8 (35.7) 191.1 (37.6) 183.0 (35.1) 177.2 (36.5) 178.1 (33.7) <.001 185.1 (36.3) <.001
LDL-Cg level, mean (SD), mg/dL 119.3 (32.1) 112.4 (27.7) 100.6 (27.6) 96.7 (30.4) 96.4 (31.6) 99.8 (28.7) <.001 101.8 (30.5) <.001
Body mass index, mean (SD), kg/m2 29.2 (4.6) 29.5 (5.3) 29.7 (5.2) 30.5 (5.4) 30.4 (6.3) 30.5 (6.0) <.001 30.1 (5.7) <.001

Statin Non-users

Unweighted sample, N 4,220 4,552 4,154 3,926 4,768 4,991

Age Range, y, %
 20–39 43.5 40.7 42.4 42.1 43.1 43.0 .59 42.4 -
 40–59 35.5 40.8 39.0 40.6 40.4 39.1 .02 39.3 -
 60– 21.0 18.5 18.6 17.3 16.5 17.9 .005 18.3 -
Female sex, % 51.3 52.0 51.8 51.2 51.9 52.3 .53 51.8 -
Racial and ethnicityd, % -
 Non-Hispanic white 68.7 70.9 70.6 70.9 67.9 66.1 .39 69.2 -
 Non-Hispanic black 11.2 11.1 11.6 11.7 11.7 11.8 .69 11.5 -
 Mexican American 7.6 7.2 8.2 8.5 9.0 9.2 .33 8.3 -
 Otherse 12.6 10.9 9.6 9.0 11.4 12.9 .88 11.1 -
Educational attainmentd, % -
 > High school 49.4 55.3 55.7 58.4 54.9 58.7 .007 55.4 -
 High school or GEDf 25.5 25.3 26.3 24.2 24.6 22.7 .14 24.8 -
 < High school 25.1 19.5 18.0 17.4 20.5 18.7 .003 19.8 -
Diabetes diagnosis, % 5.5 5.5 5.8 4.8 5.7 5.1 .56 5.4 -
Diagnosed with hyperlipidemia, % 19.3 18.5 22.0 21.6 21.7 18.8 .30 20.3 -
Total cholesterol level, mean (SD), mg/dL 203.6 (32.3) 203.1 (35.0) 202.9 (33.5) 201.1 (31.3) 200.9 (34.2) 199.6 (36.1) .002 201.8 (33.8) -
LDL-Cg level, mean (SD), mg/dL 126.2 (30.3) 121.7 (30.0) 118.9 (28.7) 118.0 (27.9) 119.5 (30.3) 119.8 (32.7) <.001 120.6 (30.1) -
Body mass index, mean (SD), kg/m2 27.9 (5.1) 27.9 (5.0) 28.0 (5.0) 28.2 (5.2) 28.2 (5.6) 28.4 (5.8) .02 28.1 (5.3) -
a

Sample size varies for certain characteristics. Each analysis accounted for an appropriate sample weight and the complex study design.

b

Trends over time were assessed using chi-squared tests for linear trends for categorical variables and linear regressions for continuous variables.

c

Comparisons between statin-users and non-users were made using pooled samples across the study period.

d

Percentages do not sum to 100% due to rounding.

e

The category includes other Hispanics and other races including multi-racial participants.

f

General Education Development.

g

Low-density lipoprotein cholesterol.